US FDA's guide on medtech appeals misses crucial question
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has issued a final Q&A document to clarify its appeals process for medical device sponsors and explain in which situations companies can ask the agency to explain in detail the reasons for its decisions.